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Somatic hypermutation (SHM) introduces nucleotide substitutions into 
immunoglobulin variable (Ig V) region genes at all four bases, but the muta-
tions at C/G and A/T pairs are achieved by distinct mechanisms. Mutations at 
C/G pairs are a direct consequence of the C®U deamination catalyzed by 
activation-induced deaminase (AID). Mutations at A/T pairs, however, require 
a second mutagenic process that occurs during patch repair of the AID-
generated U/G mismatch. Several DNA polymerases have been proposed to 
play a role in SHM, but accumulating evidence indicates that the mutations 
at A/T are overwhelmingly achieved by recruitment of DNA polymerase η.
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The initial response to antigen is pro-
vided by IgM antibodies whose binding 
sites usually exhibit a relatively low af-
fi  nity for antigen. Over the subsequent 
days and weeks, the antibody response 
matures to yield antibodies (typically of 
the IgG class) that display greatly in-
creased affi   nity for antigen. This affi   nity 
maturation is achieved during B cell 
  expansion in germinal centers by an it-
erative alternation of SHM and anti-
gen-mediated selection. SHM itself is 
characterized by the sequential intro-
duction of (typically) single nucleotide 
substitutions over a region of DNA en-
compassing the expressed Ig VH and VL 
segments. The mutations themselves can 
occur at either C/G or A/T pairs and 
can be either transitions (purine–purine 
or pyrimidine–pyrimidine substitutions) 
or transversions (a swapping of purine 
and pyrimidine). Although the entire 
process of SHM is dependent on AID 
(1, 2), the mutations at A/T pairs are 
produced by a substantially diff  erent 
mechanism from those at C/G pairs (3). 
Thus, whereas AID-catalyzed deamina-
tion of C bases can directly   explain the 
mutations at C/G pairs, those at A/T 
pairs require a second mutagenic   process. 
Accumulating genetic evi  dence (4–9), 
including new data from Delbos et al. 
(on p. 17 of this issue [10]),   increasingly 
points to a   pivotal role for DNA poly-
merase η in this A/T-  specifi  c process.
The mechanics of SHM
AID triggers somatic hypermutation by 
attacking a small number of C residues 
within the Ig V domains, deaminating 
them to U and thereby transforming a 
few C/G pairs into U/G mispairs (for 
review see reference 11). The presence 
of this uracil in DNA triggers an ancient 
pathway of DNA repair (12, 13), in 
which the uracil is excised from the 
DNA deoxyribophosphate backbone by 
the UNG uracil-DNA glycosylase. This 
yields an abasic site, which when en-
countered on the DNA template strand, 
is likely to stall the progression of the 
DNA replication fork. Such stalling re-
cruits specialized polymerases (14) that 
are able to insert a dNTP opposite the 
abasic site, despite the fact that the abasic 
site is “noninstructional.” Several trans-
lesion polymerases appear able to assist in 
this synthesis, although the evidence sup-
porting a role for the REV1 polymerase 
(15–17) is especially clear, as its specifi  c-
ity of nucleotide insertion (almost exclu-
sively dCTP) means that its absence alters 
the mutation spectrum. Mutations at C/G 
pairs can thus be envisaged as an inevita-
ble consequence of replication over sites 
of AID-catalyzed C®U deamination 
and subsequent UNG-mediated uracil 
excision (Fig. 1 A).
The mechanism by which muta-
tions are generated at A/T pairs is less 
straightforward. These mutations de-
pend on the original AID-catalyzed C-
deamination but are clearly not a direct, 
inevitable consequence of that deami-
nation. Genetic evidence suggests that 
a second mutagenic process takes place 
during patch repair of the original AID-
generated U/G mispair (18). This mi-
spair is a dual lesion in that it is both a 
mismatch and also contains a nonca-
nonical DNA base. As a mismatch, it is 
recognized by the MSH2–MSH6 het-
erodimer, which conventionally func-
tions to identify single-base mismatches 
for the purpose of initiating mismatch 
repair (Fig. 1 A). As a foreign base, it is 
recognized by the UNG uracil-DNA 
glycosylase. The patch repair process 
that generates the A/T mutations can 
be triggered by either MSH2–MSH6-
mediated or UNG-mediated recognition 
of the initiating U/G lesion, although 
analysis of mutant mice suggests that 
MSH2–MSH6-mediated recognition is 
the major pathway (18–22).
Polymerase η: the prime suspect 
for mutations at A/T
The fi   rst breakthrough in identifying 
the major DNA polymerase involved in 
mutagenesis at A/T pairs came with the 
discovery by Zeng et al. that SHM at 
A/T (but not C/G) pairs is severely de-
pressed in patients suff   ering from the 
variant form of Xeroderma pigmento-
sum (4). Xeroderma pigmentosum is a 
disease that renders patients highly sus-
ceptible to sun-induced skin cancers 
because of a defi  ciency in the cell’s abil-
ity to repair ultraviolet-induced DNA 
damage. These patients carry inactivat-
ing mutations in the gene encoding 
DNA polymerase η, a translesion poly-
merase that is thought to play a role 
in allowing the replication fork to bypass 
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are major products of ultraviolet dam-
age (23). Zeng et al. therefore proposed 
that mutations at A/T pairs were caused 
by errors of misincorporation by this 
low-fi  delity polymerase during patch 
DNA synthesis (4). A similar depression 
of mutation accumulation at A/T pairs 
was later observed after disruption of 
the gene encoding DNA polymerase η 
in the mouse (6, 8).
Although these studies demonstrated 
a major role for DNA polymerase η 
in the generation of mutations at A/T 
pairs, it is clear that this polymerase is 
not the only DNA polymerase that can 
generate the A/T mutations. Although 
defi  ciency in polymerase η diminishes 
mutation accumulation at A/T pairs, 
it does not abolish it: the mutations 
at A/T are reduced from  50% to 
 20% of the total. The striking fi  nd-
ing reported by Delbos et al. (10) is that 
mutations at A/T pairs are essentially 
totally abolished when defi  ciency in poly-
merase η is combined with defi  ciency 
in MSH2.
How should one interpret this re-
sult? Although genetics provides pow-
erful insights into what happens in vivo, 
it is a dangerous practice to extrapolate 
from the phenotype of a mutant to de-
duce what goes on in the wild type. 
Simple epistasis analysis would suggest 
that, because mutations at A/T pairs are 
obliterated by simultaneous disruption 
of MSH2 and DNA polymerase η, but 
not by either disruption on its own, 
then the two proteins should lie on dif-
ferent pathways. The matter, however, 
is not quite so simple, as single disrup-
tions in either MSH2 or polymerase η 
each yield a substantial, but not com-
plete, depression in mutation accumu-
lation at A/T pairs. The most likely 
explanation of the results is that the 
MSH2–MSH6-mediated recruitment of 
DNA polymerase η, which was previ-
ously thought to be a major pathway to 
mutations at A/T pairs, is in fact the 
overwhelming mechanism by which 
such mutations are generated. In the 
absence of DNA polymerase η, MSH2–
MSH6 recruits a backup polymerase that 
provides a low background of muta-
tions at A/T. In the absence of MSH2–
MSH6, the need to replicate across the 
UNG-generated abasic site can still re-
sult in the recruitment of DNA poly-
merase η, generating a reduced load of 
A/T mutations (Fig. 1 B). However, 
unlike the MSH2-recruited mutagenic 
patch repair, mutagenesis at A/T pairs 
as a consequence of replicating across 
the abasic site is wholly dependent on 
polymerase η.
These observations result in a pleas-
ing simplifi  cation of our view of SHM. 
Although multiple translesion polymer-
ases have been implicated in antibody 
hypermutation (for review see refer-
ences 24–26), DNA polymerase η ap-
pears to be the most dominant (if not 
the only) contributor to A/T mutations 
under normal conditions. That does not 
mean that there is no role in SHM for 
the other translesion polymerases. First, 
some other polymerase can, at least in 
the absence of polymerase η, provide 
Figure 1.  (A) A model for the major pathways of somatic hypermutation in normal mice. 
After AID-catalyzed C®U deamination, the resulting U/G mispair is recognized by either UNG or 
MSH2–MSH6. (Mutations at C/G pairs) UNG-mediated recognition leads to the generation of an 
abasic site. Replication across this abasic site (by REV1 and other translesion polymerases) results in 
the generation of both transition and transversion substitutions at C/G pairs. (Mutations at A/T pairs) 
MSH2–MSH6-mediated recognition of the U/G mispair triggers an exonuclease I– and polymerase 
η–dependent patch repair process which results in mutations at A/T pairs. (B) Backup pathways that 
may operate in mutant mice. In the absence of UNG, replication across the U/G lesion leads solely to 
transition mutations at C/G pairs (the extent to which transitions at C/G are normally attributable to 
replication across the uracil as opposed to across the abasic site is unknown). In the absence of 
polymerase η, MSH2–MSH6 appears to recruit a backup polymerase that yields some residual muta-
tions at A/T pairs. In the absence of MSH2, replication across the UNG-generated abasic site can also 
involve a mutagenic polymerase η–dependent patch repair process that generates mutations at A/T 
pairs. However, in the absence of polymerase η, no other polymerase is able to substitute for muta-
tion creation at A/T pairs in this UNG-dependent pathway.COMMENTARY
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some degree of backup mutations at A/T 
pairs in the MSH2-triggered pathway. 
Second, as discussed, the generation of 
transversion mutations at C/G pairs de-
pends on replication across an abasic site 
and this process requires a translesion 
polymerase. Nevertheless, when consid-
ering mutation creation as opposed sim-
ply to the repair of AID-induced damage, 
it seems that the dominant polymerase 
is polymerase η.
Unanswered questions
The recruitment of DNA polymerase η 
for mutagenesis at A/T pairs raises many 
questions. For example, why (and how) 
does MSH2 recruit DNA polymerase η 
to the U/G lesion? The primary role of 
MSH2–MSH6 is to initiate postreplica-
tive mismatch repair, correcting the 
  occasional errors of misincorporation 
perpetrated by the replicative DNA 
polymerases (α, δ, and ε) (27). There is 
no evidence that polymerase η nor-
mally plays any role in mismatch repair, 
which is presumably usually a process 
of high fi  delity. So, although the patch 
repair that generates mutations at A/T 
pairs is similar to conventional mis-
match repair in that it is triggered 
by  MSH2–MSH6 and likely involves 
strand degradation by exonuclease 1, it 
diff  ers from conventional mismatch re-
pair in that it is mutagenic and depends 
on polymerase η. Wilson et al. have 
provided evidence that MSH2 will as-
sociate with polymerase η and stimulate 
its activity (28). Is this association 
  specifi  c to B cells undergoing SHM? 
And what prevents polymerase η from 
being recruited during normal mis-
match repair?
The mechanism by which poly-
merase η generates the mutations at A/T 
pairs also remains uncertain. The widely 
favored view is that these mutations are 
simply attributable to errors of base 
pairing by polymerase η during the 
patch DNA synthesis. This requires 
that the errors made by polymerase η 
occur largely opposite A or T on the 
template strand (and not opposite C or 
G)—a requirement that is well sup-
ported by the extensive in vitro analysis 
of the error spectrum of purifi  ed poly-
merase η from the Kunkel lab (9). This 
would predict that the nature of the 
nucleotide substitutions introduced dur-
ing this second phase of SHM could be 
modifi  ed by altering the error spectrum 
of polymerase η.
Thus, antibody hypermutation in-
volves two distinct mutagenic processes. 
Mutations at C/G pairs are a direct 
consequence of an active assault on the 
DNA molecule itself: these deviations 
from the parental DNA sequence can 
therefore be viewed as essentially a sin 
of commission. The mutations at A/T 
pairs, however, depend on a subsequent 
and distinct mutagenic process that in-
volves polymerase η. If these mutations 
at A/T pairs are indeed simply errors 
resulting from a lack of fi  delity in poly-
merase η, then these mutations can be 
considered a sin of omission. But the sin 
of omission would never have hap-
pened were it not for the original sin of 
commission (29).
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